| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CRISPR Therapeutics AG | Director | Stock Option (Right to Buy) | 13,000 | 05 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 05 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 17:30 |
| CRSP | CRISPR Therapeutics AG | 30 May 2024 | 1 | $0 | 4 | Director | 31 May 2024, 16:15 |
| CRSP | CRISPR Therapeutics AG | 08 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 17:33 |
| CRSP | CRISPR Therapeutics AG | 09 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 17:37 |
| CRSP | CRISPR Therapeutics AG | 09 Jun 2022 | 0 | $0 | 3 | Director | 10 Jun 2022, 17:33 |